Navigation Links
Amylin Pharmaceuticals Appoints Christian Weyer, MD Senior Vice President, Research and Development
Date:6/1/2010

SAN DIEGO, June 1, 2010 /PRNewswire-FirstCall/ -- Amylin Pharmaceuticals, Inc. (Nasdaq: AMLN) today announced that Christian Weyer, MD has been appointed Senior Vice President, Research and Development. Orville Kolterman, MD, has been named Senior Vice President, Chief Medical Officer. These leadership changes will strengthen the Company's focus on preparations for a new product launch and the advancement of its late-stage development programs, both important value drivers for the Company.

During his 10-year tenure at Amylin, Dr. Weyer has made valuable contributions to the business through leadership roles in the Research, Clinical, and Corporate Development organizations, most recently as Vice President, Medical Development. In his new role, Dr. Weyer will lead Amylin's R&D organization, focusing on expanding opportunities with the Company's existing diabetes products, advancing the obesity and early diabetes pipeline, and driving research programs that support innovation and business growth.

Dr. Kolterman was previously Senior Vice President, Research and Development. In the newly created role of Chief Medical Officer, Dr. Kolterman will work to further strengthen Amylin's ties with the medical community, policy-makers, patient advocacy groups, and other audiences that will be critical in supporting the successful launch of BYDUREON™ (exenatide for extended-release injectable suspension) and driving therapeutic innovation for patients. Dr. Kolterman will also continue to lead interactions with regulatory agencies and have responsibility for global safety activities.

"The changes announced today will sharpen Amy
'/>"/>

SOURCE Amylin Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5

Related medicine technology :

1. Amylin Pharmaceuticals to Present at The Barclays Capital 2010 Global Healthcare Conference
2. Amylin and Takeda Announce Decision to Advance Development of Pramlintide/Metreleptin Combination Treatment for Obesity
3. Amylin Pharmaceuticals to Webcast Year-End Financial Results
4. Amylin Highlights 2010 Corporate Priorities at J.P. Morgan Healthcare Conference
5. Amylin Pharmaceuticals to Present at the 18th Annual Credit Suisse Healthcare Conference
6. Amylin Pharmaceuticals and Eli Lilly and Company Statement on FDAs BYETTA(R) (Exenatide) Injection Update
7. Amylin Pharmaceuticals Reports Third Quarter Financial Results
8. Amylin Pharmaceuticals Highlights New Data Supporting Therapeutic Potential of Obesity Pipeline at Obesity 2009
9. Amylin and Lilly Announce Plans to Develop Pen Device for Exenatide Once Weekly
10. Amylin Pharmaceuticals to Present Novel Data on Promising Obesity Pipeline at 2008 Annual Scientific Meeting of The Obesity Society
11. Amylin Pharmaceuticals Initiates Phase 2B Dose-Ranging Clinical Study of Pramlintide/Metreleptin Combination Treatment in Obesity
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/20/2013)... MINNEAPOLIS , May 20, 2013  Uroplasty, Inc. ... will release financial results for the fiscal fourth quarter ... market close on Thursday, May 30, 2013. The Company ... these results on Thursday, May 30, 2013 at 4:30 ... to participate in the conference call should dial 888-549-7750, ...
(Date:5/20/2013)... Quebec , May 20, 2013  Valeant Pharmaceuticals International, ... members of its senior management team will make a presentation ... on Tuesday, June 11, 2013 at 9:20 a.m. PT. The ... Los Angeles, CA. A live ... on the company,s Web site at www.valeant.com . Click ...
(Date:5/20/2013)... 20, 2013 /PRNewswire-iReach/ -- Today at American Society ... Christine Ginocchio discussed Specific Technologies blood ... identification of microorganisms producing bloodstream infection. Dr. Ginocchio ... the Division of Infectious Disease Diagnostics at North ... non-sectarian health system. (Photo: http://photos.prnewswire.com/prnh/20130520/CG16829 ...
Breaking Medicine Technology:Uroplasty To Announce Fiscal Fourth Quarter And Full Year 2013 Financial Results On May 30, 2013 2Specific Technologies Bloodstream Infection Identification Solutions Discussed at the American Society for Microbiology Conference by Award Lecturer Christine Ginocchio 2Specific Technologies Bloodstream Infection Identification Solutions Discussed at the American Society for Microbiology Conference by Award Lecturer Christine Ginocchio 3
... IDM Pharma, Inc.,(the Company) (Nasdaq: IDMI ) ... clinical protocol finalized with the U.S. Food and ... osteosarcoma patients through a compassionate access study., ... increasing number of,requests for compassionate access to L-MTP-PE," ...
... not the Only Way We Suffer - ... Allergies Impact Mood and Self-Perception, KENILWORTH, N.J. and ... about 50,million people in the United States.(1)(2) Yet, according to ... a nuisance: in today,s society allergies get little respect.,As a ...
Cached Medicine Technology:IDM Pharma Announces Availability of Mifamurtide (L-MTP-PE) Through Compassionate Access Study 2IDM Pharma Announces Availability of Mifamurtide (L-MTP-PE) Through Compassionate Access Study 3IDM Pharma Announces Availability of Mifamurtide (L-MTP-PE) Through Compassionate Access Study 4IDM Pharma Announces Availability of Mifamurtide (L-MTP-PE) Through Compassionate Access Study 5New Survey Suggests Cultural Ambivalence to Allergies Leaves Many Suffering Needlessly 2New Survey Suggests Cultural Ambivalence to Allergies Leaves Many Suffering Needlessly 3New Survey Suggests Cultural Ambivalence to Allergies Leaves Many Suffering Needlessly 4New Survey Suggests Cultural Ambivalence to Allergies Leaves Many Suffering Needlessly 5New Survey Suggests Cultural Ambivalence to Allergies Leaves Many Suffering Needlessly 6New Survey Suggests Cultural Ambivalence to Allergies Leaves Many Suffering Needlessly 7
(Date:5/21/2013)... Washington, D.C (PRWEB) May 21, 2013 ... is pleased to announce four transitions for its Board ... Dean of the Western Michigan University School of Medicine, ... Dean of Medical Education at the University of California ... F.A.C.H.E, President/Chief Executive Officer of the Nebraska Medical Center, ...
(Date:5/21/2013)... It took Willie Benitez, a heroin addict who ... on a fifteen year sentence, six months to convince ... him enough to allow Willie to start up an ... intended to name his “drug rehabilitation foundation,” meaning “no-narcotics” ... start up that class. , Early on, when ...
(Date:5/21/2013)... Leading New Jersey real estate agent, Lina ... of her favorite aspects of walkable places is the ... of the current childhood obesity epidemic that plagues the ... living. , A New York Academy of Sciences ... as a key combatant to obesity. The same article ...
(Date:5/21/2013)... (PRWEB) May 21, 2013 Dr. James ... and Director of the Sarcoma Division of the John ... New Jersey has been named one of the top ... This Week. Dr. Wittig is one of approximately ... The list was created by surveying thought leaders in ...
(Date:5/21/2013)... The Michigan Lupus Foundation will be ... , June 11th. , Meeting Details: , Tuesday, June ... Center,     Conference Room 5 (Lower Level),     1375 North Main ... to assist people with lupus and their family and ... get a better understanding of this disease and how ...
Breaking Medicine News(10 mins):Health News:New Board of Directors Leadership for The Match- National Resident Matching Program® 2Health News:New Board of Directors Leadership for The Match- National Resident Matching Program® 3Health News:Narconon Releases Report on its Very First Narconon Program, the First of 23 Reviews or Evaluations of Results up to 2009 2Health News:Narconon Releases Report on its Very First Narconon Program, the First of 23 Reviews or Evaluations of Results up to 2009 3Health News:Narconon Releases Report on its Very First Narconon Program, the First of 23 Reviews or Evaluations of Results up to 2009 4Health News:Narconon Releases Report on its Very First Narconon Program, the First of 23 Reviews or Evaluations of Results up to 2009 5Health News:New Jersey Realtor, Lina Panza, Advocates Walkable Neighborhoods to Combat Childhood Obesity 2Health News:New Jersey Realtor, Lina Panza, Advocates Walkable Neighborhoods to Combat Childhood Obesity 3Health News:James C. Wittig, MD, Selected as one of America's Top 13 Orthopaedic Oncologists 2Health News:James C. Wittig, MD, Selected as one of America's Top 13 Orthopaedic Oncologists 3
... you,re born with, study finds , TUESDAY, June 16 (HealthDay ... blood pressure doesn,t mean you,re doomed to have it, a ... that blood pressure is affected by genes," said Dr. Nora ... North Carolina and lead author of a report on the ...
... Corp. (Nasdaq: HMSY ) today announced that it will ... be held June 17-18, 2009 in New York City. , ... SVP and Chief Financial Officer of HMS Holdings Corp., will present ... , HMS Holdings Corp. (HMS) is the leader in coordination ...
... depicting a biomedical researcher, with breast cancer, in search of ... The Foundation for Biomedical Research (FBR) announced today its ... the 30th Annual Telly Awards competition. Founded in 1978, the ... and cable TV commercials and programs, the finest video and ...
... too, is unclear, expert says, , TUESDAY, June 16 (HealthDay ... according to new research from Spain. , The study found ... fruit (more vitamins, folic acid and fiber and less protein ... lead author, Jaime Mendiola, a researcher at the University of ...
... Nutritional Consultant and Nutrition Expert, Robin De-Ivy Allen conducted a survey ... it possible for a person to eat their way to a ... actually make a person more marketable as an employment candidate? , ... ) , , 68% of survey responders believe that a ...
... Duke University engineers have taken a first step ... combining chemotherapy with heat administered from the end of ... should be technically possible to treat brain tumors without ... surgery, systemic chemotherapy or radiation. The bioengineers designed ...
Cached Medicine News:Health News:Lifestyle May Counter Blood Pressure Genes 2Health News:Lifestyle May Counter Blood Pressure Genes 3Health News:Breast Cancer TV Spot Wins Four Telly Awards 2Health News:Fruits and Veggies May Improve Sperm Quality 2Health News:Nutrition Expert Conducts Survey and Reveals How to Eat Your Way to a New Job 2Health News:Potential for noninvasive brain tumor treatment 2
... membrane parasite soluble lysate ... as antigen. Since this ... than the recombinant kit, ... use two ELISA techniques ...
The Cellabs T. cruzi IgG CELISA is a direct ELISA kit designed to detect antibodies produced during T. cruzi infections (Chagas disease)....
... The dual-electrode SPL defibrillator lead ... design, offering the flexibility and ... Designed for the physician who ... shocking coils, the SPL lead ...
... The Medtronic Subcutaneous Lead ... implanted subcutaneously with the use ... Model 6996T. Improved SQ design ... DFTs, a fast and easy ...
Medicine Products: